Ryvu Therapeutics S.A. (WSE:RVU)
Poland
· Delayed Price · Currency is PLN 23.45
-0.45 (-1.88%)
Apr 29, 2026, 9:01 AM CET
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 552.57 million as of April 28, 2026. Its market cap has increased by 5.75% in one year.
Market Cap
552.57M
Enterprise Value
540.79M
Revenue
87.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.45
Market Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 552.57M, an increase of 877.95%. That is a compound annual growth rate of 16.66%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Captor Therapeutics Spolka Akcyjna | 508.27M |
| Bioceltix | 408.24M |
| BIOTON | 359.34M |
| Synthaverse | 236.37M |
| Mabion | 133.82M |
| Molecure | 118.06M |
| NanoGroup | 108.06M |
| Poltreg | 80.21M |